Template:Amyloidosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(33 intermediate revisions by 11 users not shown) | |||
Line 3: | Line 3: | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
Amyloidosis Microchapters | '''Amyloidosis Microchapters''' | ||
''' | |||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
! | ! | ||
Line 28: | Line 27: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Amyloidosis historical | [[Amyloidosis historical Perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 35: | Line 34: | ||
! | ! | ||
[[Amyloidosis classification|Classification]] | [[Amyloidosis classification|Classification]] | ||
|- | :• [[Primary amyloidosis]] | ||
:• [[Secondary amyloidosis]] | |||
:• [[Familial amyloidosis]] | |||
:• [[Wild-type (senile) amyloidosis]] | |||
:• [[Cardiac amyloidosis]] | |||
:• [[Beta-2 microglobulin related amyloidosis]] | |||
:• [[Gelsolin related amyloidosis]] | |||
:• [[Lysozyme amyloid related amyloidosis]] | |||
:• [[Leucocyte cell-derived chemotaxin 2 related amyloidosis]] | |||
:• [[Fibrinogen A alpha-chain associated amyloidosis]] | |||
|- | |||
! | ! | ||
Line 41: | Line 59: | ||
! | ! | ||
[[Amyloidosis pathophysiology|Pathophysiology]] | [[Amyloidosis pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
Line 55: | Line 74: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
Line 69: | Line 89: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Amyloidosis screening|Screening]] | [[Amyloidosis screening|Screening ]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Amyloidosis natural history, complications and prognosis|Natural History, Complications and Prognosis]] | [[Amyloidosis natural history, complications and prognosis|Natural History, Complications and Prognosis ]] | ||
|- | |- | ||
! | ! | ||
Line 81: | Line 102: | ||
! | ! | ||
Diagnosis | Diagnosis | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Amyloidosis diagnostic study of choice|Diagnostic Study of Choice]] | |||
|- | |- | ||
! | ! | ||
Line 110: | Line 137: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Amyloidosis | [[Amyloidosis X-ray|X-ray ]] | ||
|- | |- | ||
! | ! | ||
Line 116: | Line 143: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Amyloidosis | [[Amyloidosis echocardiography and ultrasound|Echocardiography and Ultrasound]] | ||
|- | |- | ||
! | ! | ||
Line 122: | Line 149: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Amyloidosis | [[Amyloidosis CT scan|CT scan]] | ||
|- | |- | ||
! | ! | ||
Line 128: | Line 155: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Amyloidosis | [[Amyloidosis MRI|MRI]] | ||
|- | |- | ||
! | ! | ||
Line 166: | Line 193: | ||
[[Amyloidosis primary prevention|Primary Prevention]] | [[Amyloidosis primary prevention|Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
Line 172: | Line 199: | ||
[[Amyloidosis secondary prevention|Secondary Prevention]] | [[Amyloidosis secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
Line 184: | Line 211: | ||
[[Amyloidosis future or investigational therapies|Future or Investigational Therapies]] | [[Amyloidosis future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Amyloidosis case study one|Case #1]] | |||
|- | |||
! | |||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " | ||
Line 277: | Line 315: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}] | [http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}] | ||
|- | |- | ||
! | ! | ||
Line 283: | Line 321: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+ | [http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Psoriasis}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Psoriasis] | ||
|- | |- | ||
! | ! |
Latest revision as of 15:29, 10 February 2020
Amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Amyloidosis On the Web |
American Roentgen Ray Society Images of Amyloidosis |